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Xuan Xu, M.S. 
University of Pittsburgh, 2006
   In 2004, our group found with TMS protected quinine and quinidine as catalysts, β-lactones 
can be synthesized with high diastereoselectivity and enantioselectivity by acyl-halide aldehyde 
cyclocondensation (AAC) reactions (Scheme I).  
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Scheme I. AAC reaction with alkaloid catalysts 
Based on the success of AAC methodology in our group, we want to check the potential for 
the application of the same protocol in the asymmetric β-lactam synthesis (Scheme II). Instead of 
aldehyde, imines will be chosen as substrates for the [2+2] cycloaddition. 
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Scheme II. Hypothesized reaction for the synthesis of β–lactams 
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  We want to know that with some activation group at nitrogen atom, whether we can get some 
active substrates. In addition, if the imine substrates are not very active, would Lewis acid 
provide sufficient activations to imines? If the substituted ketenes are substrates, what would the 
diastereoselectivity be? 
The activation group at N atom was chosen as nitrobenzenesulfonyl group and the R1 
substituent can be aromatic groups (Scheme III). The yields and ee values were good. 
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Scheme III. Reaction between simple ketene and Ns-protected imine substrates 
For the substituted ketenes, good diastereoselectivity wasn’t achieved although the yields and 
ee values were still good (scheme IV).  
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Scheme IV. Reaction between methyl ketene and Ns-protected imine substrates 
In this project, we extend the successful protocol in AAC chemistry to the asymmetric β–
lactam synthesis. In our system, benzenesulfonyl group is proved to be a good choice of 
activation group. Because of the small energy difference in the transition state for the reaction 
between alkyl group substituted ketene and activated imine substrate, low diastereoselectivity 
was obtained.   
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1.0  INTRODUCTION 
1.1 BIOACTIVE β–LACTAM COMPOUNDS 
Azetidin-2-one, also called β-Lactam, is a four member cyclic amide which was first 
synthesized by Staudinger in 1907.1 Because of the discovery of penicillin in 1928 by Fleming 
and its structural confirmation by X-ray crystallography,2 the bioactivity of β-lactam compounds 
has been investigated intensively.3 Before 1970, penicillin and cephalosporins were the 
antibiotics that attracted most synthetic effort. Subsequently, many derivatives have been 
developed (Figure 1). Carbacephems are analogues of cephalosporins that are also used as 
antibiotics. The trans relationship between substituents at C3 and C4 in the β–lactam ring is 
different with the cis one in penicillin and cephalosporin. GV 104326, a tricyclic β-lactam 
(trinem), is a highly potent, broad-spectrum antibacterial agent which also contains the trans 
relationship. Recently, some β-lactams were found to be potential cholesterol absorption 
inhibitor.4  
 1 
NS
O
COOH
H
NR
O
H H
Penicillin
N
O
H
NR1
O
H H
S
R2
COOH
Cephalosporin
N
O
O
H H
HO
COOH
NH2
Carbapenem
N
O
OMe
OMe
HH
Cholesterol absorption Inhibitor
N
COOH
OMe
O
H
OH
GV 104326 (tribactam)  
Figure  1 Bioactive β-lactam compounds 
1.2 DERIVATIZATION OF β–LACTAM COMPOUNDS 
In addition to their bioactivities, enatiomerically pure β-lactams are versatile building blocks 
for the synthesis of a variety of natural products, such as β-amino acids, oligopeptides, labeled 
peptides and azetidines.5 Because of the β-lactams’ highly strained four-member ring, the 
cleavage of any of the four bonds is possible (Scheme 1). The N1-C2 bond can be easily cleaved 
by nucleophiles (e.g. oxygen, nitrogen, and carbon) and get β-amino acid derivatives as 
products.6 When R2 is amino group and R3 is aromatic group, palladium-catalyzed 
hydrogenolysis is a good way to break N1-C4 bond and get α–amino acid derived peptides.5b The 
ring-opening at C2-C3 bond of α–hydroxy β-lactams can also produce α–amino acid derivatives 
via N-carboxy α–amino acid anhydride (NCA) intermediates.7 Selective cleavage of the C3-C4 
bond is rare. 
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Scheme 1 Derivatization of β-lactams with bond cleavage 
1.3 METHODS FOR THE SYNTHESIS OF β–LACTAM COMPOUNDS 
Inspired by the pharmacological applications of β-lactams and due to the limitations 
associated with their biosynthesis, chemical synthesis of this kind of compounds has attracted 
considerable attention over the last 80 years.5a, 8 The strained four-member ring which constitutes 
the core structure of all β-lactam antibiotics is the main challenge point in the synthetic effort for 
synthesis of these compounds.  
The four-member ring of β–lactam can be constructed by any of the four single-bond 
formations or by [2+2] cycloaddition (Scheme 2). The formation of the amide (N1-C2) bond is 
the most obvious approach and was utilized in the synthesis of penicillin.9 In the four single-
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bond constructions, C2-C3 bond formation was rare. One methodology involving a 
tributylstannane-mediated ring closure has been reported (Scheme 3).10 Despite the poor yield, 
this method gave an alternative way to synthesize chiral β–lactam considering the starting 
material can be prepared from readily available β–amino acids. For the C3-C4 bond formation, in 
a simple sense, the C-C bond construction involves the formation of a nucleophilic center at C3 
and an electrophilic center at C4, or vice versa.11 The biosynthetic way of the β-lactam synthesis 
is mainly focused on the formation of C4-N1 bond.12 A lot of approaches have been developed to 
construct this bond. The idea is the intramolecular displacement of a leaving group attached to C4 
with activated nitrogen (Figure 2).13  
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Scheme 2 Methods for β-lactam ring construction 
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Scheme 3 Formation of C2-C3 bond in the β–lactam ring 
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Figure 2 C4-N1 bond formation 
 
Compared with the single-bond construction approach of β–lactam synthesis, the ketene-imine 
cycloaddition which includes carbenoid insertion and the Staudinger reaction is more widely 
used.8c, g Due to the ready availability of both imines and ketenes, the Staudinger reaction has 
provided a useful and economical approach for the synthesis of β–lactams. In addition, the 
ketene-imine cycloaddition is more efficient, which constructs the β–lactam four-member ring in 
just one step reaction. 
The mechanism for Staudinger reaction is that the electrophilic ketene is attacked by lone pair 
electrons of imine nitrogen and the zwitterionic enolate is formed. The following conrotatory 
ring closure forms the β-lactam (Scheme 4).14 In most of cases, cis β-lactams are the major or the 
only products from E-imines. For this diastereoselectivity, some explanation has been 
established (Scheme 5).15 Because the LUMO of the ketene carbonyl group is coplanar to the 
substituents of ketene (Figure 3), if the C=O bond is attacked by imines in an orthogonal 
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approach, thus an intermediate is generated in which the planes of the imine and the ketene 
should be perpendicular to each other. In addition, the attack of imine from the least hindered 
side is the most possible way for the formation of zwitterionic enolate. A conrotatory ring 
closure of the intermediate 1 will form the thermodynamically less stable cis β-lactam. For the 
cyclic imines, the formation of intermediate 2 will get the trans β-lactam. If the intermediate 1 
was attacked by nucleophiles and the C=N bond was broken, the bond rotation will cause the 
formation of both intermediates 1 and 2. Depending on the steric hindrance between R and R1, 
the different value of cis-trans ratio will appear in Staudinger reaction. Additionally, the cis 
product can be isomerized to more stable trans one with strong base.16 
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Scheme 4 Mechanism for the Staudinger reaction 
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Scheme 5 Explanation for the diastereoselectivity 
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Figure 3. HOMO and LUMO of Ketene 
Generally, the asymmetric induction in the Staudinger reaction comes from the chiral imines 
or chiral ketenes, or both. The possible reason for the enantioselectivity is illustrated in Scheme 6. 
The imine can be placed on the top face or bottom face based on the substrate structure. Before 
the ring closure, the central C-N bond has to rotate toward an eclipsed arrangement. Based on the 
principle of least motion, the rotation will be only 90 degree. In order to avoid the interaction 
between the hydrogen of ketene and R1 of the imine, the ring will be closed in only one direction. 
Thus, based on the substrate structure, one enantiomer will be preferred. 
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Scheme 6 Explanation for the asymmetric induction 
Although Staudinger reaction is widely used for β–lactam synthesis, most of the approaches 
are based on the use of chiral precursors, either imines or ketenes.8g In recent years, some 
asymmetric methods have been developed by Lectka and Fu’s group.17 Lectka’s methodology is 
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based on the combined action of a pair of Brønsted bases (Scheme 7). The acyl chloride is 
dehydrochlorinated at low temperature by tertiary nucleophiles (e. g benzoylquinine). The 
resulting ketenes are trapped by the nucleophile and form chiral zwitterionic enolates which 
attack electrophilic imines and get β-lactams. The strong bases (e. g. “proton sponge”) can form 
thermodynamically stable hydrochloride salt and reproduce the tertiary nucleophiles. So, the 
alkaloid catalysts are also called “proton shuttle”. Due to the polarity reversal of ketenes and 
imines, this mechanism is different with the standard Staudinger reaction. 
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Scheme 7 Lectka’s asymmetric synthesis of β–lactam compounds 
Using planar-chiral azaferrocene heterocyclic compounds to activate ketenes, Fu found 
another efficient way to get cis β-lactams with high yields and enatioselecties (Scheme 8). Very 
recently, this group found when the protecting group of imines is switched from tosyl group to 
triflate, the diastereoselectivity is reversed.18 The proposed explanation is that due to the strong 
electron withdrawing ability of Tf group, the nucleophilic catalyst will add to imines first. The 
resulting anion will attack ketene and form the enolate (Scheme 9). That is the reason for the 
reversed diastereoselectivity. 
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Scheme 8 Fu’s β–lactam synthesis 
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Scheme 9 Proposed Mechanism for the reversed diastereoselectivity 
The carbenoid insertion method was developed by Hegedus’ group.8c The chromium complex 
is prepared from chromium hexacarbonyl and organolithium reagents, which is air-stable and 
easily handled. Due to the strong electron withdrawing ability of Cr(CO)5 group, the carbene 
carbon is quite electrophilic. Irradiated with visible light through Pyrex, one of the four cis CO 
groups is reversely inserted into the metal-carbon double bond. The resulting species has ketene-
like reactivity and can react with imines, olefins, and carboxylic acid derivatives (Scheme 10). 
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Scheme10 Chromium carbene complexes for β-lactam synthesis 
In addition to above methods, the ester enolate-imine condensation, also called Gilman-
Speeter reaction, is another popular way for β–lactam synthesis (Scheme 11).19, 8b In 1997, 
Tomioka reported the first example of a direct catalytic enantioselective synthesis of β-lactam by 
using this method.20 The active reagent is a ternary complex (comprising LDA, the ester enolate, 
and tridentate amino diether) which afforded β–lactam compounds in high yield and good ee 
value. 
X
O
R
base
X
O
R
H
NR2
R1
R1 X
ON
R2
N
R R1
R2O
O
Me Me
O
Ph Ph
Me2N O
MeO
10%
N
PMP
Ph
+
LDA 4 equiv.
toulene, -200C, 1.5h
N
O
Me
Me
Ph
H
PMP
99% yield
88% ee
 
Scheme 11 Gilman-Speeter reaction in β–lactam synthesis 
Although a lot of methods about the β–lactam synthesis have been developed since 
Staudinger’s first synthesis in 1907, the catalytic and asymmetric version of this ketene-imine 
[2+2] cycloaddition is still rare. Considering our group’s success in the synthesis of β-lactone,21 
we want to check whether we can extend the same idea to the β–lactam synthesis. The following 
questions are those we need to answer: Can we control the enatioselectivity with TMS-
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Quinine/TMS-Quinidine catalysts and achieve high ee value? Can we obtain high 
diastereoselectivity if the substituted ketenes are used? Does the Lewis acid have the similar 
effect as in the AAC reaction? In the following chapter, I will discuss the research results in the 
β–lactam synthesis and try to answer these questions. 
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2.0   REACTION DEVELOPMENT AND DISCUSSION 
2.1 BACKGROUND 
  In 2004, our group found with TMS protected quinine and quinidine as catalysts, β-lactones 
can be synthesized with high diastereoselectivity and enantioselectivity by acyl-halide aldehyde 
cyclocondensation (AAC) reactions (Scheme 12). With the appropriate choice of Lewis acids, 
the quench between catalysts which are Lewis bases and Lewis acids can be avoided. The Lewis 
acid additive is believed to activate both aldehyde and enolate and form a closed transition state, 
which facilitates β-lactones formation (Scheme 13). 
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Scheme 12 AAC reaction with alkaloid catalysts 
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Scheme 13 Proposed mechanism for the AAC reaction 
Based on the success of AAC methodology in our group, we want to check the potential for 
the application of the same protocol in the asymmetric β-lactam synthesis (Scheme 14).    
Similar as in AAC reactions, the ketene would be formed in situ and activated by cinchona 
alkaloid catalysts to form the zwitterionic enolate. Instead of aldehyde, imines will be chosen as 
substrates for the [2+2] cycloaddition. Compared with carbonyl compounds, due to the lower 
electronegativity of nitrogen atom, the LUMO of the C=N bond will be higher than the LUMO 
of the C=O bond. Thus, the C=N bond in imine substrate is less electrophilic (Figure 4). If imine 
substrates are activated and electrophilic enough (decreasing the LUMO), the enolate 
intermediate 3 will attack the electrophilic carbon atom and form the C-C bond much easier. The 
subsequent ring closure will form the 4-member β-lactam ring. This stepwise [2+2] 
cycloaddition is similar as the proposed mechanism in AAC chemistry.  
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Scheme 14 Hypothesized reaction way for the synthesis of β–lactams 
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Figure 4. The LUMO of C=N and C=O bond 
For the activation of imines, one way is to choose the electron withdrawing groups as 
substitution groups of imines and another way is to use Lewis acid to activate imines. In this 
project, we want to testify the hypothesized reaction way and explore the possible ways to 
activate the imine substrates. In Lectka’s research, they used α–imino esters as substrates which 
have activation group attached to carbon atom. We want to know that if we add some activation 
group at nitrogen atom, whether we can get some active substrates. In addition, if the imine 
substrates are not very active, would Lewis acid provide sufficient activations to imines? If the 
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substituted ketenes are substrates, what would diastereoselectivity be? In the following section, I 
will try to answer these questions. 
2.2 REACTION DEVELOPMENT AND DISCUSSION 
2.2.1 Choice of Substrates 
2.2.1.1 Imine Substrates 
In order to increase the electrophilicity of imine substrates, 2- and 4-nitrobenzenesulfonyl 
group were chosen as substitution groups at nitrogen atom. Benzenesulfonyl group is strongly 
electron-withdraw and the nitro group attached to the benzene ring will decrease the electron 
density at benzene ring further. In addition, Fukuyama has reported one mild way to deprotect 
this kind of protection group.22 Considering the stabilizing effect of aromatic groups, they were 
chosen as the substitution group at carbon atom. In addition, the choice of aromatic group 
prevents the possible tautomerization between imine and enamine because there is no α–
hydrogen can be deprotonated. In 2000, Ishigedani’s group reported a way to prepare such kind 
of imines.23 N-Alkylidenesulfonamides (ArCH=NSO2Ar’) can be easily prepared by 
condensation of aromatic aldehyde (ArCH=O) with arenesulfonamides (H2NSO2Ar’) in the 
presence of triethoxysilane, which acts as solvent and dehydrating reagent. The side product–
ethanol is removed by Dean-Stark. After simple recrystalization, the pure product can be 
obtained. In addition, two unsaturated imines were prepared in the same way (Table 1). 
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Table 1 Imine substrates preparation 
R
O
H
SO2NH2
X (EtO)4Si
160oC
N
Ns
+
R H
4
Y
X=NO2, Y=H or X=H, Y=NO2
 
entry R1 substrate  yield %
 
a  
 a75 
 
b F  
 a63 
 
c 
 
 
a51 
  
 
78  
d 
 
e  
 
71 
 
f 
Cl  
 
64 
  
g 
O2N
MeO
 
51 
  
Ph  h 
aThe Ns group in entry a-c was 1-sulfonyl-4-nitrobenzene. For the other entries, Ns group was 1-
sulfonyl-2-nitrobenzene. 
72 
Considering the wide utilization of t-butyloxycarbonyl (Boc) and carbobenzyloxy (Cbz) group as 
amine protection groups, imine substrates with these groups attached to N atom were also 
prepared.24 The condensation of benzyl aldehyde, sodium benzenesulfinate and cabamates 
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formed the corresponding sulfonamide sulfone, which was refluxed in THF in the presence of 
potassium carbonate. After filtration of the reaction mixture, the pure imines can be obtained 
(Scheme 15). Compared with the nosylate protected imines, Boc and Cbz groups have weaker 
electron withdrawing ability, which will decrease the electrophilicity of substrates and the 
addition of Lewis acid may be necessary.  
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R=tBu,yield 69%
     Bz, yield 83%5
PhSO2Na
 
Scheme 15 Procedure for imine substrate preparation 
To check the substrate scope, some other imine substrates were also prepared according to the 
known procedure.25 From 6a to 6c, the activation groups attached to N atom have decreased 
electron withdrawing ability. 6d and 6e are aliphatic imines, which can tautomerize to 
corresponding enamines. 6f has a propargyl group and can be elaborated further.   
N
Tf
H
N
Bs
Ph H
N
Ph H
MeO
N
H
Ts
N
O
O
N
Ph
N
oNs
H
TMS
6 a 6 b 6c 6 d
6 e 6 f
Tf= Triflate
Bs= Benzenesulfonyl
24% 58% 88%
67% 30%
90%
 
Figure 5. Some other imine substrates 
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2.2.1.2 Ketene Substrates 
  Simple and mono alkyl group substituted ketenes were chosen as substrate. Similar to the AAC 
chemistry, ketenes can be formed in situ by dehydrohalogenation of acetyl halide at low 
temperature.26 With the slow addition of acyl chloride by syringe pump, the possible ketene 
dimerization is avoided because of the low concentration of ketene and low reaction temperature. 
Considering the increase steric hindrance with the larger alkyl group which will deteriorate the 
reaction, main effort was put on simple and methyl substituted ketenes. 
2.2.2 Results 
2.2.2.1 Simple ketene and Ns-Imine Substrates 
  The imine substrate 4a and simple ketene were chosen as starting point for the exploration of 
reaction condition. Based on the established AAC procedure, a test reaction was run. 10 mol% 
TMS-quinine and imine substrate were dissolved in CH2Cl2 and cooled to -78 0C . Acyl chloride 
was dissolved in CH2Cl2 and added to the reaction system slowly by syringe pump addition. The 
mixture was stirred -78 0C for 5 hours and then warmed to room temperature. The solid product 
was collected by filtration and washed with small amount of CH2Cl2. The yield was acceptable 
(65%) and the ee value was high (95%). If the workup procedure was changed to extraction, the 
ee value decreased to about 85%. It seems the β–lactam ring will be temporarily opened and 
cause the enatioselectivity erosion. Due to the strong electron withdraw ability of 
nitrobenzenesulfonyl group, without the addition of Lewis acid, the substrate was still activate 
enough. From this starting point, we want to fix the activation group as Ns group and then can 
explore the effect of substitution groups at C atom systematically. For aromatic groups, with the 
choice of substitution group at benzene ring, the electron density at C atom can be tuned. If the 
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electron withdrawing group is attached to the benzene ring, it will decrease the electron density 
in the aromatic ring and make the imine carbon atom more electrophilic. On the contrary, 
electing donating substituents on the benzene ring will increase the electron density and 
deactivate the imine substrates. We want to know: what is the scope of the substituents on the 
benzene ring? Is Lewis acid additive effective to activate the imine substrates? The results are 
summarized in Table 2. In entry b, the para-fluoro group is strongly electron withdrawing. Good 
yield (69%) and ee value (98%) were obtained. Similarly, in entry f, the ortho-chloro group is 
also very electron withdrawing and good result was also achieved (yield 80%, ee 96%). These 
two results indicate that with electron withdraw substituents on the benzene ring, the imine 
substrates are activated enough. For entry c to e, three conjugated aromatic substrates were tested. 
Because the conjugated bi-phenyl and naphthyl groups have the similar electrostatic property as 
phenyl group, we believe the reactivity will be also at the same level. The observed results 
confirmed this expectation (entry c, yield 87%, ee 99%; entry d, yield 57%, ee 99%; entry e, 
yield 80%, ee 99%). When the para-methoxy group was attached to the benzene ring, the 
increased electron density decreased the reactivity of the imine substrate. No product was 
observed even with the addition of Lewis acid (LiI, 3 eq.). In order to tune the electron density in 
the benzene ring, a nitro group was added to the meta position. Because of the strong electron 
withdrawing ability of nitro group, good result was gotten (entry g, yield 82%, ee 99%). It seems 
that electron donating substituents on the benzene ring are not tolerated in this reaction system. 
For entry h and i, the C=C bond is conjugated with aromatic ring and can also stabilize the 
carbon atom. But, the products are not as stable as other trials. The low yield is a result of the 
lost in the purification process (entry h); the racemic product is thought to be the result of self-
epimerization of the furan ring (entry i). 
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Table 2  Asymmetric Synthesis of β-lactams 
+Cl
O   TMS-quinine
 iPr2NEt, CH2Cl2
        -78oC
N
O
R1
N
Ns
R1
Ns
H
4 7  
substrate  yield % ee%bentry 
aa 4a 65 c 95 
ab 4b 69 c 98 
ac 4c 87 c,d99 
4d 57 d 99 d 
4e 80 d99 e 
4f 80 96 f 
4g 82 99 g 
4h h 26 90 
4i i 72 
a Entry a-c were Dr. Cheng Zhu’s result. b Enantiomer excess ratio was determined by comparing two 
enantiomers retention time with HPLC. cThe Ns group in entry a-c was 1-sulfonyl-4-nitrobenzene. For the 
other entries, Ns group was 1-sulfonyl-2-nitrobenzene. dThe solvent was THF. 
For the lost of chirality in entry i, the possible reason is that the electronrich 2-furyl 
substitution group will pump the lone pair electron of oxygen to furan ring. This electron transfer 
at the conjugate system causes the four-membered β–lactam ring temporally opened. Because 
the ring closure has no facial selectivity, the product is racemized (Scheme 16). 
N
O oNs
O
N
O oNs
O
N
O oNs
O
 
Scheme 16   Possible explanation for the racemization of entry i 
--- 
2.2.2.2 Monosubstitued ketenes and Ns-Imine Substrates 
  With the successful cycloaddition reaction between simple ketene and Ns protected imines, we 
want to extend the reaction scope to substituted ketenes (Table 3). Although the reactivity was 
still good (entry a, h, i, j) for methyl ketenes, the satisfied diastereoselectivity didn’t be achieved. 
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Due to the little low solubility in THF, the conversion was decreased for some trials (entry e, f, 
and g). The addition of Lewis acid seemed helpful for the reactivity but no increase for 
diastereoselectivity (entry a). Increased steric hindrance decreased the reactivity (entry c and d). 
Optimized condition for AAC reaction27 also didn’t function well (entry f). 
Table 3 Reactions between Substituted Ketenes and Ns-imines 
O
Cl
R1
N
O
R2R1
10mol% TMS-QN
iPr2NEt, solvent
-780C
+
N
Ns
R2
Ns
 
aMgCl2 was added (a, 2eq.; g, 1 eq.). bReaction time/temperature: a, overnight/-780C; b and c, overnight/-250C; d to 
j, 5 hours/-780C. c Diastereomer ratios and conversion were determined by 1H NMR of crude product mixtures. Dr. 
ratio was cis:trans. d Some ee. values were checked: entry a, cis 99% and tran 94%; entry j, cis 34% and tran 98%. 
eThese are Dr. Cheng Zhu’s results. 
Although the diastereoselectivity is not good, if the two diastereomers can be separated easily, 
the reaction will still be useful. So, several large scale (2 mmol) reactions are tried. The total 
yield for the two diastereomers is good and ee value for each diastereomers is also satisfactory 
(Table 4). The absolute configuration was confirmed by the crystals structure of 8 a, which is 
exact same as we have expected. 
Table 4 Asymmetric Synthesis of β-lactam with methyl substituted ketene 
entryb R1 Imine Solvent Dr.c % Conv.c
a ,d, ea Me 4 a 2:1 CH2Cl2:THF 1:1 100 
e b Me 4 a 2:1 CH2Cl2:THF 1.6:1 70 
e c Et 4 a CH2Cl2 1.5:1 75 
d iPr 4 c CH2Cl2 1:2 61 
e Me 4 c  2:1 CH2Cl2:THF 1:1 44 
f Me 4 c 9:1 CH2Cl2:DMF 1.2:1 75 
ag Me 4 c 2:1 CH2Cl2:THF 1.5:1 43 
 h Me 4 d CH2Cl2 1.5:1 100 
i Me 4 e CH2Cl2 1.5:1 91 
d j Me 4 c CH2Cl2 1:1.2 96 
+Cl
O   TMS-quinine 10%
 iPr2NEt, CH2Cl2
        -78oC
N
O
R1
N
Ns
R1
Ns
H Me 8
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entry Imine yield %a Separated yield %b Dr. cis:transc ee % 
a 4 a 86 cis:14%, trans:24% 1:1.4 cis:99 trans:98 
b 4 b 88 cis:13%, trans:56% 1:1.1 cis:99 trans:98 
c 4 c 66 --- 1:2.3 cis:34 trans:98 
4 e 67 cis:22%, trans:12% d 1:0.9 
aThe yields were the combination yields of diastereomers. bThe separated yield for each of the 
diastereomers included products from recrystalization and ISCO separation. Entry c can’t get 
separated diastereomer. The difference between the two yields was accounted to unseparated 
mixtures and lost on the column. cThe ratio was determined by comparing the integration value 
of two specific peaks in NMR spectra. 
N
O S
O
O
NO2
Me
8 a  
Figure 6. X-Ray Structure of 8a 
2.2.2.3 Ketenes and Cbz-Imine Substrates 
cis:85 trans:99 
Although the yields and ee values are satisfactory, the low diastereoselectivity of the reactions 
with methyl ketene is still a problem. Cheng got some potential results in previous tests with cbz 
protected imines. So, they were chosen as next target (Table 5). However, due to the weaker 
electron withdrawing ability of cbz group, there was no reaction under previous reaction 
condition. Considering the success of AAC reaction in our group, Lewis acid activation is a 
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possible way to increase the reactivity of substrates. With the appropriate choice of Lewis acid, 
the substrate reactivity did get some improvement (entry i, j). But, with the amount of Lewis acid 
increase, substrates began to decompose (entry b, c and h). Some transition metal salts were also 
tested as Lewis acid and no effect was found (entry d, e). The best diastereoselectivity was 
achieved with LiClO4 as Lewis acid (entry k, 3:1; entry l, 6:1). For other trials, the ratio was 
lower than 1.5. 
Table 5 Asymmetric β-lactam Synthesis with cbz protected imines 
O
Cl
R1
N
O
PhR1
10mol% TMS-QN
iPr2NEt, solvent
Lewis acid, -780C
+
N
Ph
CbzO
O
 
entrya R1 Lewis Acid Solventb % Conv.c % Dr.c
a H LiI, 1 eq. 10:1 CH2Cl2:Et2O 23 -- 
b H LiI, 3 eq. 10:1 CH2Cl2:Et2O S.M. dec. -- 
c H LiClO4, 1 eq. 2:1 CH2Cl2:Et2O S.M. dec. -- 
d H Zn(OTf)2, 0.1 eq. 2:1 CH2Cl2:Et2O No RXN -- 
e H Yb(OTf)3,0.1 eq. 2:1 CH2Cl2:Et2O No RXN -- 
f H Mg(OTf) ,0.1 eq. 2
Al(OTf) ,0.1 eq. 
2:1 CH2Cl2:E O t2
2:1 CH
54 -- 
g H 3
Al(OTf)
2Cl2:Et2O 51 -- 
h H 3, 1 eq. 2:1 CH2Cl2:Et2O S.M. dec. -- 
i H MgCl , 1 eq. 2
LiOTf, 1 eq. 
2:1 CH2Cl2:Et2O 73 -- 
j H 2:1 CH2Cl2:Et2O 54 -- 
k Me LiClO4, 1 eq. 2:1 CH2Cl2:Et2O 77 3:1 
l Me LiClO4, 1 eq. 2:1 CH2Cl2:Et O 2
9:1 CH Cl :DMF
43 6:1 
m Me LiI, 1 eq. 2 2
2:1 CH
33 1:1 
dn Me LiClO4, 1 eq. 2Cl2:Et2O 66 1:1 
o Me Mg(OTf) ,0.2 eq 2
LiOTf, 1 eq. 
2:1 CH2Cl2:Et2O 7 1.2:1 
p Me 2:1 CH2Cl2:Et2O No RXN -- 
q Me MgCl2,1 eq 2:1 CH2Cl2:Et2O S.M. dec. -- 
r Me Al(OTf)3, 1 eq. 2:1 CH2Cl2:Et2O <10 1:1 
aEntry (a-c, k, l) were Dr. Cheng Zhu’s result. bReaction time/temperature: 14 hours/-780C, 
except entry l. For entry l, the temperature was -250C. cDiastereomer ratios and conversion were 
determined by 1H NMR of crude product mixtures. Dr. ratio was cis:trans. dMe-QN was used as 
catalyst. 
2.2.2.4 ketenes and Other Imine Substrates 
  From previous experiments, we know nosylate group can activate the imine substrates. In order 
to tune the electron density at C=N bond, imine substrates with the function groups having 
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different electron withdrawing ability were tested. In addition, some aliphatic imine substrates 
were also tested. The results are summarized in Table 6. When the activation group attached to N 
atom is Tf, the imine substrate is not very stable under reaction condition. Although Fu got good 
trans diastereoselectivity in his system,18 no reaction was found in our trials. For entry b, c and f, 
benzenesulfonyl group can supply enough activation and get good reactivity for the substrates. In 
entry c, d and e, without sulfonyl group, the benzene ring can’t make the C=N bond electrophilic 
enough. The ortho methoxy group increases the eletrondensity at benzene ring and decreases the 
reactivity of imine substrate further. With the addition of Lewis acid, there is still no reaction. 
Similar observation for entry g and h, the isoindoline-1, 3-dione unit in 6e can’t activate the C=N 
bond. For substrate 6f, it is not very stable and only decomposed starting material was found. 
Based on the above data, we can see that benzene sulfonyl group is also a good choice as 
activation group in our system. 
Table 6 Reactions between Ketenes and Other Imine Substrates 
O
Cl
R1
N
O
R2R1
10mol% TMS-QN
iPr2NEt, solvent
+
N
R3
R2
R3
Lewis Acid  
entrya R1 Imine Solvent Lewis Acid % Convb
a Me 6a CH2Cl2 --- No RXN ab H 6b CH Cl2 2
2:1 CH
--- 93 
ac Me 6b  2Cl2:Et2O LiClO4, 1 eq. 79 ad H 6c 2:1 CH2Cl :Et O 2 2
2:1 CH Cl :THF 
LiClO , 1 eq. 4
ZnCl , 1 eq. 
No RXN 
ae H 6c  2 2
CH Cl
2
--- 
No RXN 
af H 6d 2 2
2:1 CH Cl :THF 
72c
ag H 6e 2 2
CH
LiClO , 1 eq. 4
ZnCl , 1 eq. 
No RXN 
ah H 6e 2Cl2 No RXN 
aThese are Dr. Cheng Zhu’s results. bConversion was determined by 1H NMR of crude product mixtures.. 
cThis is the separated yield. 
2
--- i H 6f CH2Cl2 No RXN 
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2.2.3 Discussion 
2.2.3.1 Proposed Mechanism 
Because of the extraordinary activity of simple ketene and mono-alkyl substituted ketenes, the 
lone pair electron of imine N atom will easily attack them even at low temperature. Just as 
previously mentioned, this is the first step of Staudinger reaction. In order to exclude this 
possible background reaction, some control experiments were also run (Scheme 17). Without the 
addition of alkaloid catalysts, NEt3 and Hunig’s base were added as base and nucleophile. 
Because of the steric hindrance of Hunig’s base, which decreases the nucleophilicity, there was 
no reaction. On contrast, in situ formed ketene was attacked by nucleophilic NEt3 and formed 
activated enolate. So, there should have no interference come from the ammonium salt. The 
possible mechanism is like this (Scheme 18). The ketene was in situ generated from acyl chloride 
through dehydrohalogenation reaction with Hunig’s base. Then, it was attacked by chiral tertiary 
amine, which formed the zwitterionic intermediate. Due to the strong electron withdrawing 
ability of sulfonyl group, the nosylate protected imine was strongly electrophilic and attacked by 
the enolate quickly. The resulting intermediate did the conrotatory ring closure and released the 
catalyst. Based on Romo26 and Lectka’s17b observation, alkaloid catalyst can act as “proton 
shuttle” under reaction condition. It may dehydrohalogenate the acyl chloride and the salt will 
transfer the proton to the stronger base. Lectka reported that Hunig’s base will compete with 
benzoylquinine as catalyst in reaction. In our system, such interference wasn’t observed. In both 
of Lectka and Romo’s system, the preferred solvent is toluene. The ammonium salt will 
precipitate and not interfere with the reaction in toluene. But the low solubility of substrates and 
catalyst in toluene will decrease the yield. In our system, polar solvent, such as THF, can be used. 
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Scheme 17  Control experiment 
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Scheme 18 Proposed Mechanism for β–lactam synthesis 
2.2.3.2 Explanation for the Stereochemical Outcome 
For the ketene-imine cycloaddition, the nosylate protected imine substrates are activated 
enough. Their reactivity is also verified by good yields (see Table 1, Table 3). For the high 
enantioselectivity achieved in reactions, it will be correlated to the distinguished structure of 
Cinchona alkaloid catalysts. 
In 1982, Wynberg reported a ketene-chloral cycloaddition with quinidine as catalyst.28 He 
proposed a model to explain the high enatioselectivity (scheme 19). In this model, he used 1, 2-
dimethylpyrrolidine to take place quinidine. In the left TS, the chloral approaches the catalyst 
with the trichloromethyl group facing away from the methyl group of the catalyst to avoid steric 
strain. In the right TS, the CCl3 group orients itself away from the ring methylene protons. From 
either TS, same product can be obtained. The author suggested that the chiral center adjacent to 
the nitrogen of quinuclidine part determines the chirality of product.  
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Scheme 19 Wynberg’s stereochemical model 
Although this model can partly explain the reaction, it is too simple to represent the unique 
structure of this kind of catalysts. Cinchona alkaloids are composed of two relatively rigid 
entities. One is an aromatic quinoline ring and the other is an aliphatic quinuclidine ring. They 
are connected by two C-C bonds. Although quinine and quinidine look like mirror images, they 
form a diastereomeric pair when the configuration at C8 and C9 are considered (Figure 7). 
Sometimes, they are called “pseudoenantiomers”. In 1989, a detail conformational study of 
Cinchona alkaloids was reported by Wynberg’s group.29 Base on the data from NMR, molecular 
mechanic calculation and X-ray structure, four minimum energy conformations in solution were 
presented for quinidine (Figure 7). In two “open” conformations, the quinuclidine ring points 
away from the quinoline ring; in two “closed” conformations, the quinuclidine ring points toward 
the quinoline ring. The difference between two conformations in each category is the orientation 
of H8 and H9. In conformation 1, the orientation of two H atoms is almost anti relation; in 
conformation 2, a staggered orientation is formed. 
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OPEN 1 OPEN 2 CLOSE 1 CLOSE 2  
Figure 7. The four minimum energy conformations of quinidine 
For the conformation of quinine and its derivatives, Wynberg proposed that if methoxy group 
is attached at C9 position, the “close 1” conformation is preferred. In my calculation about the 
low energy conformation of TMS-quinine catalyst, the “open 2” conformation has the minimum 
energy (Figure 8).30 In his research about the diastereoselectivity of the Mukaiyama aldol 
reaction, Heathcock31 proposed that the enolate C=C bond antiperiplanar to the aldehyde C=O 
bond is the preferred transition state. Similarly, in the β–lactam synthesis, the imine C=N bond is 
also antiperiplanar to the enolate C=C bond, which can minimize the nonbonding interaction 
between nosylate group and quinoline ring of the catalyst. For the facial selectivity, enolate 
attacks the C=N bond from re-face will cause less strain of the transition state based on the data 
from calculation (Figure 9). Considering these two reasons, the high enatioselectivity can be 
explained. 
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Figure 8. The minimum energy conformation of TMS-quinine catalyst 
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Figure 9. Explanation for stereochemical outcome 
Just as mentioned previously, for methyl substituted ketene, the diastereoselectivity for the 
cycloaddition is not good. Although, for each diastereomer, the ee values are higher than 90%, 
the dr ration is only about 1:1. This can be explained by the models in Figure 10. From the result 
of calculation, the quinine moiety is preferably trans to the methyl substitution across the C=C 
bond. This makes the top face of the ketene C=C bond which is re-face is completely open to the 
imine electrophile. For the low diastereoselectivity, neither of the two faces of the imine 
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substrate can supply enough bias based on the data from the calculation. So, in order to increase 
the diastereoselectivity, we need to find a way to differentiate the steric environment around the 
C=N bond. 
Re-Face Approach
Re-Face attack
Si-Face attack  
Figure 10. Explanation for the Enantioselectivity and Diastereoselectivity 
2.2.3.3 Substitution group effect of imine substrate 
From the experiment result, we can found that the properly activated imine substrate is very 
important for the success of β–lactam synthesis. If the activation group attached to N atom has 
too strong electron withdrawing ability, the imine is easily decomposed under the reaction 
condition (substrate 6a). Benzenesulfonyl group is a good choice as activation group in our 
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system. From Ns to Ts, although the electrophilic property of the imine substrate is decreased, 
good yields are still achieved. The decreased ee values can be contributed to the lower transition 
state difference (substrate 4, 6b, 6d). When the C=N bond is more electronrich, the reactivity of 
imine decreases more (substrate 5, 6c, 6e). With the addition of Lewis acid, the imine substrate 6 
can be partly activated and get some conversion. For substrate 6c and 6e, there is no reaction at 
all even with Lewis acid activation. With the appropriate activation group at N atom, the 
substitution groups at C atom can be aryl group, alkyl group (substrate 4, 6d). One exception is 
4-methoxybenzyl group. No reaction was found for this substrate.  
N
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Ph H
N
Bs
Ph H
N
Ph H
MeO
N
H
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N
O
O
N
Ph
N
oNs
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2.3 DERIVATIZATION OF β-LACTAM COMPOUNDS 
With the optical pure β-lactam in hand, we wish to examine the possibility of derivatization of 
β-lactam compounds. Our group has developed some methods to open the β–lactone ring (eq 
1).32 Hard nucleophile, such as alkoxy group, will attack the carbonyl group of β–lactone. After 
the addition-elimination process, aldol product can be obtained. Soft nucleophile, such as 
mercapto group, will attack C4 in a SN2 fashion and get β–amino acids. Based on this 
observation, we want to extend this idea to the ring opening of β–lactam. Using some “hard 
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nucleophile”, the 4-member ring can be opened at C1 position and β–amino acid derivatives can 
be obtained. Originally, the standard Fukuyama’s protocol was tried to remove the Ns group 
before the ring opening (Scheme 20).22 Because the nucleophilic sulfur compounds which are 
used to form the Meisenheimer complexes with Ns group will also attack C3 position of β–
lactam and make starting material decomposed, successful deprotection is achieved only after the 
ring opening process. First, benzyl amine was tried and the ring opening process was successful. 
But, with two amide subunits in the structure, this compound was high polar and it was difficult 
to remove the nosylate group. We tried to use methoxy group to open the four member ring and 
then do the deprotection. This process was successful. After getting the amino ester, it was used 
to open another β-lactam ring, which was also successful (Scheme 21). So, we get a β-peptide 
from β-lactam. It is a starting point for the synthesis of useful β-peptide materials and a 
complement to the derivatization of β–lactone from AAC chemistry. 
O
O
R SN2
Addition-
elimination
Nu
O OH
Nu= OR, NR2
HO R
O Nu
Nu= CR3, NR2, SR
(1)
 
SO2
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X
+
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X=NO2, Y=H or
X=H, Y=NO2  
Scheme 20 Fukuyama’s protocol for the deprotection of Ns group 
 
 32 
N
O S
O
O
NO2
NaOMe, MeOH
-780C
HN
S
O
O
NO2
O
MeO
PhS, 1.2 eq.
K2CO3 , 3 eq.
DMF,  500C
NH2O
MeO
NO SO
O
NO2
DMF, 500C
O
MeO N
H
N
H
O
S NO2
O
O
9   83%
11 75%
10  42%
 
Scheme 21 Derivatization of β–lactam compounds 
2.4 CONCLUSION 
In this project, we extend the successful protocol in AAC chemistry to the asymmetric β–
lactam synthesis. With appropriate choice of activation group at N atom, the C=N bond of imine 
substrate can be electrophilic enough. The nucleophilic zwitterionic enolate formed from ketene-
catalyst addition will attack the imine substrate quickly. In our system, benzenesulfonyl group is 
proved to be a good choice of activation group. Because of the small energy difference in the 
transition state for the reaction between alkyl group substituted ketene and activated imine 
substrate, low diastereoselectivity was obtained. If the electron withdrawing ability of activation 
group decreases, the reactivity of imine substrate is also decreased. The addition of Lewis acid 
has no obvious effect for increasing the reactivity of imine substrate.    
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3.0  EXPERIMENTAL PROCEDURE 
General Information:  Optical rotations were measured on a Perkin-Elmer 241 digital 
polarimeter with a sodium lamp at ambient temperature and are reported as follows: [α]λ (c 
g/100mL). Infrared spectra were recorded on a Nicolet Avatar 360 FT-IR spectrometer.  NMR 
spectra were recorded on a Bruker Avance-300 (300 MHz) spectrometer with chemical shifts 
reported relative to residual CHCl3 (7.27 ppm) for 1H and CDCl3 (77.23 ppm) for 13C NMR 
spectra, CH2Cl2 (5.32 ppm) for 1H and CD2Cl2 (54.00 ppm) for 13C NMR spectra, DMSO (2.50 
ppm) for 1H and (CD3)2SO (39.52 ppm) for 13C NMR spectra. Analytical high performance 
liquid chromatography (HPLC) was performed on a Hewlett Packard 1100 liquid chromatograph 
equipped with a variable wavelength UV detector (deuterium lamp, 190-600 nm) using a Daicel 
ChiracelTM AS-H column (250 x 4.6 mm) (Daicel Inc.) or Daicel ChiralpakTM AD column (250 x 
4.6 mm) (Daicel Inc.) and HPLC-grade isopropanol and hexanes as the eluting solvents. Unless 
otherwise stated, all reactions were carried out in dry glassware under a nitrogen atmosphere 
using standard inert atmosphere techniques for the manipulation of solvents and reagents.  
Anhydrous solvents (CH2Cl2, THF, diethyl ether and toluene) were obtained by passage through 
successive alumina and Q5 reactant-packed columns on a solvent purification system. Acetyl 
chloride and propyl chloride were purified according standard procedure. The other 
commercially available chemicals were directly used without further purification. 
3.1 PREPARATION OF IMINE SUBSTRATES   
 37 
General Procedure A: The general procedure is same as literature indicated.22 A sulfonamide, 
an aldehyde (1.1 eq.), and tetraethyl orthosilicate (1.1 eq.) were combined in a flask with a Dean-
Stark, and the mixture was heated at 160°C under nitrogen for 6h. After cooling to room 
temperature, the reaction mixture was dissolved in warm ethyl acetate, treated with n-hexane and 
allowed to stand at room temperature. The crystal were collected by filtration, washed with n-
hexane, and dried. 
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(E)-N-(naphthalen-2-ylmethylene)-2-nitrobenzenesulfonamide (4d): 2.02 
g (10 mmol, 1.0 eq.) of sulfonamide, 1.72 g aldehyde (11 mmol, 1.1 eq.) and 
2.45 ml (11 mmol, 1.1 eq.) of (EtO)4Si were heated in a flask equipped with 
a Dean-Stark apparatus for 6h. After cooling to ambient temperature, 
crystallization from EtOAc/hexane gave 2.64 g (78%) of the title compound 
as pale orange powder: mp 158-159°C; IR(KBr): 1587, 1570, 1535, 1366, 1163, 1055 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 9.24 (s, 1H), 8.44 (d, J = 6.3 Hz, 2H), 8.08 (dd, J = 8.6, 1.5 Hz 1H), 
8.00 (d, J = 7.9 Hz, 1H), 7.94-7.89 (m, 2H), 7.85-7.79 (m, 3H), 7.70-7.58 (m, 2H); 13C NMR (75 
MHz, CDCl3) δ 173.8, 154.8, 148.7, 137.4, 137.1, 134.7, 132.9, 132.7, 132.2, 132.1, 130.1, 
129.8, 129.4, 128.3, 127.6, 124.9, 124.3; HRMS m/z calcd for C17H12N2O4S: 340.0518; found: 
340.0512. 
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(E)-N-(biphenyl-4-ylmethylene)-2-nitrobenzenesulfonamide (4e): 4.04 g (20 
mmol, 1.0 eq.) of sulfonamide, 3.83 g aldehyde (21 mmol, 1.05 eq.) and 4.91 ml 
(22 mmol, 1.1 eq.) of (EtO)4Si were heated in a flask equipped with a Dean-
Stark apparatus for 6h. After cooling to ambient temperature, crystallization 
from EtOAc/hexane gave 5.19 g (71%) of the title compound as yellow powder: 
mp 159-161°C; IR(KBr): 1593, 1547, 1370, 1167, 1058 cm-1; 1H NMR (300 MHz, DMSO-d6) δ 
9. 15 (s, 1H), 8.30 (dd, J = 7.0, 1.9 Hz, 1H), 8.17 (d, J = 8.3, Hz 2H), 8.12-8.09 (m, 1H), 8.04-
7.98 (m, 2H), 7.96-7.91 (m, 2H), 7.86-7.77(m, 2H), 7.54-7.42(m, 2H); 13C NMR (75 MHz, 
DMSO-d6) δ 172.8, 148.0, 147.1, 138.4, 135.9, 133.4, 133.2, 132.6, 132.3, 131.2, 130.7, 129.7, 
129.1, 128.9, 127.5, 127.3, 127.1, 125.0, 124.2; HRMS m/z calcd for C19H14N2O4S: 366.0674; 
found: 366.0672. 
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(E)-N-(2-chlorobenzylidene)-2-nitrobenzenesulfonamide (4f): 1.96 g (9.70 
mmol, 1.0 eq.) of sulfonamide, 1.23 ml aldehyde (11 mmol, 1.1 eq.) and 2.45 ml 
(11 mmol, 1.1 eq.) of (EtO)4Si were heated in a flask equipped with a Dean-
Stark apparatus for 6h. After cooling to ambient temperature, crystallization 
from EtOAc/hexane gave 2.00 g (64%) of the title compound as white needles: 
mp 167-168°C; IR(KBr): 1589, 1552, 1366, 1330,1164, 1122, 1057 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 9. 58 (s, 1H), 8.40 (dd, J = 6.5, 2.9 Hz, 1H), 8.19 (d, J = 7.9, Hz 1H), 7.89-7.79 (m, 
3H), 7.61-7.51 (m, 2H), 7.41-7.36 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 170.5, 148.9, 139.9, 
136.5, 135.0, 132.8, 132.3, 131.7, 130.9, 130.6, 129.8, 127.7, 125.1; HRMS m/z calcd for (M++H) 
C13H10N2O4SCl: 325.0050; found: 325.0058. 
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(E)-N-(4-methoxy-3-nitrobenzylidene)-2-nitrobenzenesulfonamide (4g): 1.97 
g(9.75 mmol, 1.0 eq.) of sulfonamide, 1.99 g aldehyde(11 mmol, 1.1 eq.) and 
2.45 ml (11 mmol, 1.1 eq.) of (EtO)4Si were heated in a flask equipped with a 
Dean-Stark apparatus for 6h. After cooling to ambient temperature, 
crystallization from CH2Cl2/hexane gave 1.80 g (51%) of the title compound as 
pale brown powder: mp 129-131°C; IR(KBr): 1597, 1538, 1364, 1326,1159,  1000 cm-1; 1H 
NMR (300 MHz, CDCl3) δ 9.01 (s, 1H), 8.49 (d, J = 1.5 Hz, 1H), 8.41-8.36 (m, 1H), 8.34(dd, 
J=8.7, 1.3 HZ 1H), 7.87-7.76 (m, 3H), 7.26 (d, J=8.7 HZ 1H), 4.08(s, 1H); 13C NMR (75 MHz, 
CDCl3) δ 170.8, 158.1, 148.7, 140.4, 137.7, 135.1, 132.9, 132.3, 131.7, 128.5, 125.0, 124.7, 
114.3, 57.4; HRMS m/z calcd for C14H11N3O7S: 365.0317; found: 365.0314. 
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(E)-2-nitro-N-((E)-3-phenylallylidene)benzenesulfonamide (4h): 
1.99 g(9.85 mmol, 1.0 eq.) of sulfonamide, 1.58 ml aldehyde(11 mmol, 
1.1 eq.) and 2.45 ml (11 mmol, 1.1 eq.) of (EtO)4Si were heated in a 
flask equipped with a Dean-Stark apparatus for 6h. After cooling to 
ambient temperature, crystallization from EtOAc/hexane gave 2.23 g 
(72%) of the title compound as brown powder: mp 147-148°C; IR(KBr): 1579, 1540, 1362, 
1321,1163, 1125, 1056 cm-1; 1H NMR (300 MHz, CDCl3) δ 8.84(d, J = 9.5 Hz, 1H), 8.39-8.34 
(m, 1H), 7.84-7.77 (m, 3H), 7.67 (d, J=15.7 HZ 1H), 7.63-7.60 (m, 2H), 7.51-7.43 (m, 3H), 
7.07(dd, J = 15.7, 9.5 Hz 1H); 13C NMR (75 MHz, DMSO-d6) δ 174.2, 157.0, 147.9, 135.7, 
134.1, 133.1, 132.0, 131.2, 129.8, 129.2(2C), 129.1(2C), 124.9, 124.3; HRMS m/z calcd for 
C15H12N2O4S: 316.0518; found: 316.050. 
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(E)-N-((E)-3-(furan-2-yl)allylidene)-2-nitrobenzenesulfonamide (4i): 
3.94 g(19.5 mmol, 1.0 eq.) of sulfonamide, 2.69 g aldehyde(22 mmol, 
1.1 eq.) and 4.91 ml (22 mmol, 1.1 eq.) of (EtO)4Si were heated in a 
flask equipped with a Dean-Stark apparatus for 6h. After cooling to 
ambient temperature, crystallization from EtOAc/hexane gave 4.14 g (69%) solid compound. 
The solid was washed with 10 ml EtOAc and 1.76 g product was obtained. Later, 1.28 g solid 
was precipitated from the filtrate. The combined yield was 3.04 g (51%). The title compound is 
yellow powder: mp 148-149°C; IR(KBr): 1630, 1595, 1545, 1466, 1213, , 1164, 1122 cm-1; 1H 
NMR (300 MHz, CDCl3) δ8.73(d, J = 9.8 Hz, 1H), 8.38-8.33 (m, 1H), 7.84-7.75 (m, 3H), 7.62 (d, 
J=1.5 HZ 1H), 7.39 (d, J=15.4 HZ 1H), 6.92 (d, J=9.8 HZ 1H), 6.87(dd, J = 13.0, 6.5 Hz 1H), 
6.58(dd, J = 3.5, 1.7 Hz 1H); 13C NMR (75 MHz, CDCl3) δ 174.0, 151.2, 148.7, 147.4, 140.5, 
134.7, 132.8, 132.5, 132.2, 124.9, 122.1, 119.0, 113.7; HRMS m/z calcd for C13H10N2O5S: 
306.0310; found: 306.0315. 
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General Procedure B: The general procedure is same as literature indicated.1 For the 
synthesis of 5b, some modification was made. Because both of these two imines are known, full 
characterization isn’t given. 
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(E)-tert-butyl benzylidenecarbamate (5a): Sulfone product was prepared as 
follows: a mixture of benzaldehyde (5.3 g, 50 mmol), t-butyl carbamate (2.93 g, 
25 mmol), sodium benzene sulfite (10.15 g, 62 mmol), and formic acid (2.3 g, 
Ph
N
H
O
O
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50 mmol) in 25 mL of methanol and 50 mL of water was stirred at room temperature for 21 h. 
The solid material was filtered, washed with water and ether, and then dried under reduced 
pressure to give 6.06 g (69%) of sulfone. A stirred mixture of 4.00 g (11.5 mmol) of sulfone and 
9.40 g (68.0 mmol) of dry potassium carbonate in 134 mL of THF under argon was refluxed for 
12 h. The mixture was then allowed to cool to room temperature and filtered through Celite, and 
the filtrate was concentrated to leave 2.36 g (100%) imine. 1H NMR (300 MHz, CDCl3) δ 8.94(s, 
1H), 7.98-7.92 (m, 2H), 7.60-7.46 (m, 3H), 1.61(s, 9H). 
(E)-benzyl benzylidenecarbamate (5b): A mixture of benzaldehyde 
(2.12 g, 20 mmol), benzyl carbamate (3.02 g, 20 mmol), sodium benzene 
sulfite (3.61 g, 22 mmol) in 25 mL of fomic acid and 25 mL of water was 
stirred at room temperature for 14 h. The solid material was filtered, washed with water and ether, 
and then dried under reduced pressure to give 6.35 g (83 %) of sulfone. A stirred mixture of 6.35 
g (16.64 mmol) of sulfone and 13.58 g (98.0 mmol) of dry potassium carbonate in 150 mL of 
THF under argon was refluxed for 12 h. The mixture was then allowed to cool to room 
temperature and filtered through Celite, and the filtrate was concentrated to leave 3.98 g (100%) 
imine. 1H NMR (300 MHz, CDCl3) δ 9.04(s, 1H), 8.02-8.00 (m, 2H), 7.57-7.33 (m, 8H), 5.42 (s, 
2H). 
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(E)-trifluoro-N-(naphthalen-2-ylmethylene)methanesulfonamide (6a): 
This compound was synthesized according to known procedure.2 
Because this is a known compound, full characterization isn’t provided. 
1H NMR (300 MHz, CDCl3) δ9.32 (s, 1H), 8.51 (s, 1H), 8.14 (dd, J = 8.6, 1.7 Hz 1H), 8.05 (d, J 
= 6.0 Hz 1H), 8.00 (d, J =8.8 Hz 1H), 7.96 (d, J = 8.2 Hz 1H), 7.76 (td, J = 6.9, 1.2 Hz 1H), 7.67 
(td, J = 8.1, 1.2 Hz 1H). 
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(E)-2-nitro-N-(3-(trimethylsilyl)prop-2-
ynylidene)benzenesulfonamide (6f): This compound was synthesized 
according to known procedure.3 A suspension of MgSO4 (0.7062 g, 
5.87 mmol) in 10 ml toluene was added by a solution of N-Sulfinyl-o-
nitrobenzenesulfonamide (0.2558 g, 1.03 mmol) in 5 ml dry CH2Cl2. After cooling to -30 0C, the 
aldehyde (0.2020 g, 1.6 mmol) and BF3.Et2O (1 mmol) were added subsequently. The solution 
was stirred for 3 hours. Then, the solvent was removed by high vacuum. The compound (95.3 
mg, yield 30%) was recrystallized from CH2Cl2/Hexane as pale yellow needles. 1H NMR (300 
MHz, CDCl3) δ8.40-8.36 (m, 1H), 8.29 (s, 1H), 7.87-7.80 (m, 3H), 0.28 (s, 9H). 
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3.2 SYNTHESIS OF β–LACTAM COMPOUNDS
(R)-4-(naphthalen-2-yl)-1-(2-nitrophenylsulfonyl)azetidin-2-one (7d): 
To a solution of 0.0205 g (0.052 mmol, 0.05 eq.) of TMS-quinine and 0.376 
g (1.1 mmol, 1.0 eq.) of imine in 10 ml of THF at -78°C was added 0.44 
ml(2.5 mmol, 2.5 eq.) of N, N-diisopropylethylamine. Then, a solution of 
0.142 ml (2.0 mmol, 2.0 eq.) of acetyl chloride in 0.5 ml THF was added over 2h via a syringe 
pump. After being stirred at -78°C for 5h, the reaction mixture was poured into 60 ml of CH2Cl2 
and 15 ml of water. The organic layer was separated and subsequently washed with 10 ml 
saturated Na2CO3 solution and 10 ml of brine. The organic layers was dried (Na2SO4), filtered 
and concentrated in vacuo. Crystallization from CH2Cl2/hexane gave 0.240 g (57%)  of the title 
N
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compound as pale yellow powder: mp 147-148°C; Separation of  the enantiomers by Chiral 
HPLC(Daicel ChiralpakTM AD column , flow rate 1.0 ml/min, 40% iPrOH, 60% hexane, Tr 
17.0(R) and 15.1(S) min) provided the enantiomer ratio: (R) : (S) =99.5: 0.5(99% ee); [α]D +252° 
(c 1.32, DMF);  IR(KBr): 1812, 1547, 1367, 1173, 1137, 1043 cm-1; 1H NMR (300 MHz, CD2Cl2) 
δ7.89-7.74 (m, 5H), 7.70-7.59 (m, 2H), 7.55-7.49 (m, 2H), 7.44 (dd, J = 8.6, 1.5 Hz 1H), 7.39-
7.34( m, 1H), 5.51(dd, J = 6.4, 3.5 Hz 1H), 3.67(dd, J =16.2, 6.4 Hz 1H), 3.27(dd, J = 16.2, 3.5 
Hz 1H); 13C NMR (75 MHz, DMSO-d6) δ 163.9, 147.2, 136.0, 133.8, 132.9, 132.7, 132.4, 130.7, 
129.8, 128.5, 127.9, 127.5, 126.8, 126.6, 126.5, 124.7, 123.7, 57.9, 46.4; HRMS m/z calcd for 
.0613; found: 382.0623. C19H14N2O5S: 382
(R)-4-(biphenyl-4-yl)-1-(2-nitrophenylsulfonyl)azetidin-2-one (7e): To a 
solution of 0.0235 g (0.059 mmol, 0.05 eq.) of TMS-quinine and 0.373 g 
(1.02 mmol, 1.0 eq.) of imine in 10 ml of THF at -78°C was added 0.44 
ml(2.5 mmol, 2.5 eq.) of N, N-diisopropylethylamine. Then, a solution of 
0.142 ml (2.0 mmol, 2.0 eq.) of acetyl chloride in 0.5 ml THF was added over 2h via a syringe 
pump. After being stirred at -78°C for 5h, the reaction mixture was poured into 50 ml of EtOAc 
and 15 ml of water. The organic layer was separated and subsequently washed with 15 ml 
saturated Na2CO3 solution and 10 ml of brine. The organic layers was dried (Na2SO4), filtered 
and concentrated in vacuo. Crystallization from CH2Cl2/hexane gave 0.333 g (80%)  of the title 
compound as pale yellow powder: mp 138-139°C; Separation of  the enantiomers by Chiral 
HPLC(Daicel ChiralpakTM AD column , flow rate 1.0 ml/min, 40% iPrOH, 60% hexane, Tr 
25.4(R) and 22.5(S) min) provided the enantiomer ratio: (R) : (S) =99.5: 0.5(99% ee); [α]D +338° 
(c 1.38, CH2Cl2);  IR(KBr): 1808, 1546, 1376, 1171, 1120, 1047 cm-1; 1H NMR (300 MHz, 
CD2Cl2) δ7.92 (d, J = 7.8 Hz 1H), 7.73(d, J = 3.9 Hz 2H), 7.59-7.43 (m, 9H), 7.40-7.35( m, 1H), 
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5.41(dd, J = 6.4, 3.5 Hz 1H), 3.63(dd, J =16.2, 6.4 Hz 1H), 3.22(dd, J = 16.2, 3.5 Hz 1H); 13C 
NMR (75 MHz, CD2Cl2) δ 163.1, 147.9, 142.1, 140.2, 135.4, 135.2, 132.3, 132.0, 131.2, 
129.0(2C), 127.8, 127.5(2C), 127.3(2C), 127.1(2C), 124.5, 57.9, 47.1; HRMS m/z calcd for 
C21H16N2O5S: 408.0780; found: 408.0774. 
 (R)-4-(2-chlorophenyl)-1-(2-nitrophenylsulfonyl)azetidin-2-one (7f): To a 
solution of 0.0431 g (0.109 mmol, 0.1 eq.) of TMS-quinine and 0.329 g 
(1.015 mmol, 1.0 eq.) of imine in 10 ml of CH2Cl2 at -78°C was added 0.44 
ml(2.5 mmol, 2.5 eq.) of N, N-diisopropylethylamine. Then, a solution of 
0.142 ml (2.0 mmol, 2.0 eq.) of acetyl chloride in 0.5 ml CH2Cl2 was added over 2h via a syringe 
pump. After being stirred at -78°C for 5h, the reaction mixture was poured into 50 ml of EtOAc 
and 15 ml of water. The organic layer was separated and subsequently washed with 15 ml 
saturated Na2CO3 solution and 10 ml of brine. The organic layers was dried (Na2SO4), filtered 
and concentrated in vacuo. Crystallization from CHCl3/hexane gave 0.296 g (80%)  of the title 
compound as white needles: mp 148-149°C; Separation of  the enantiomers by Chiral 
HPLC(Daicel ChiralpakTM AD column , flow rate 1.0 ml/min, 40% iPrOH, 60% hexane, Tr 
10.0(R) and 8.7(S) min) provided the enantiomer ratio: (R) : (S) =98.0: 2.0(96% ee); [α]D +467° 
(c 1.27, CHCl3);  IR(KBr): 1797, 1544, 1359, 1176, 1131, 1058 cm-1; 1H NMR (300 MHz, 
CD2Cl2) δ8.12 (dd, J = 7.8, 1.2 Hz 1H), 7.85-7.68 (m, 3H), 7.59-7.56( m, 1H), 7.41-7.38( m, 1H), 
7.33-7.24( m, 2H), 5.80(dd, J = 6.6, 3.5 Hz 1H), 3.69(dd, J =16.2, 6.6 Hz 1H), 3.08(dd, J = 16.2, 
3.5 Hz 1H); 13C NMR (75 MHz, CD2Cl2) δ 163.5, 148.6, 136.2, 135.0, 133.1, 133.0, 132.8, 
131.3, 130.6, 130.4, 128.0, 127.8, 125.1, 56.2, 47.0; HRMS m/z calcd for C15H11N2O5SCl: 
366.0077; found: 366.0091. 
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 (R)-4-(4-methoxy-3-nitrophenyl)-1-(2-nitrophenylsulfonyl)azetidin-2-
one (7g): To a solution of 0.0231 g (0.058 mmol, 0.1 eq.) of TMS-quinine 
and 0.189 g (0.518 mmol, 0.5 eq.) of imine in 10 ml of THF at -78°C was 
added 0.44 ml(2.5 mmol, 2.5 eq.) of N, N-diisopropylethylamine. Then, a 
solution of 0.142 ml (2.0 mmol, 2.0 eq.) of acetyl chloride in 0.5 ml 
CH2Cl2 was added over 2h via a syringe pump. After being stirred at -78°C for 5h, the reaction 
mixture was poured into 60 ml of CH2Cl2 and 10 ml of water. The organic layer was separated 
and subsequently washed with 15 ml saturated Na2CO3 solution and 10 ml of brine. The organic 
layers was dried (Na2SO4), filtered and concentrated in vacuo. Crystallization from 
CH2Cl2/hexane gave 0.172 g (82%)  of the title compound as pale yellow powder: mp 84-86°C; 
Separation of  the enantiomers by Chiral HPLC (Daicel ChiralpakTM AD column , flow rate 1.0 
ml/min, 40% iPrOH, 60% hexane, Tr 27.3(R) and 29.6(S) min) provided the enantiomer ratio: 
(R) : (S) =99.5: 0.5(99% ee); [α]D +261° (c 1.78, CHCl3);  IR(KBr): 1802, 1537, 1366, 1284, 
1173, 1128 cm-1; 1H NMR (300 MHz, CDCl3) δ8.15 (d, J = 7.4 Hz 1H), 7.90 (d, J=2.2 HZ, 1H), 
7.84-7.68( m, 4H), 7.11 (d, J=8.7 HZ, 1H),  5.46(dd, J = 6.4, 3.4 Hz 1H), 3.97(s, 1 H), 3.64(dd, J 
=16.2, 6.4 Hz 1H), 3.15(dd, J = 16.2, 3.4 Hz 1H); 13C NMR (75 MHz, CD2Cl2) δ 162.8, 153.6, 
148.2, 139.8, 135.7, 132.7, 132.6, 132.5, 131.4, 129.2, 124.8, 124.2, 114.5, 57.1, 57.0, 46.9; 
HRMS m/z calcd for (M+Na+) C16H13N3O8SNa: 430.0300; found: 430.0321. 
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 (R)-(E)-1-(2-nitrophenylsulfonyl)-4-styrylazetidin-2-one (7h): To a 
solution of 0.0437 g (0.11 mmol, 0.1 eq.) of TMS-quinine and 0.299 g (0.95 
mmol, 1.0 eq.) of imine in 10 ml of CH2Cl2 at -78°C was added 0.44 ml(2.5 
mmol, 2.5 eq.) of N, N-diisopropylethylamine. Then, a solution of 0.142 ml 
(2.0 mmol, 2.0 eq.) of acetyl chloride in 0.5 ml CH2Cl2 was added over 2h 
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via a syringe pump. After being stirred at -78°C for 5h, the reaction mixture was poured into 60 
ml of CH2Cl2 and 15 ml of water. The organic layer was separated and subsequently washed 
with 15 ml saturated Na2CO3 solution and 10 ml of brine. The organic layers was dried (Na2SO4), 
filtered and concentrated in vacuo. Crystallization from CHCl3/hexane gave 0.088 g (26%)  of 
the title compound as pale yellow needles: mp 108-110°C; Separation of  the enantiomers by 
Chiral HPLC (Daicel ChiralpakTM AD column , flow rate 1.0 ml/min, 40% iPrOH, 60% hexane, 
Tr 6.6(R) and 8.9(S) min) provided the enantiomer ratio: (R) : (S) =95: 5(90% ee); [α]D +° (c 
1.78, CHCl3);  IR(KBr): 1622, 1580, 1314, 1289, 1174, 1153, 1090 cm-1; 1H NMR (300 MHz, 
CDCl3) δ8.29 (d, J = 7.4 Hz 1H), 7.82-7.69( m, 3H), 7.40-7.28( m, 5H), 6.84(d, J=15.7 HZ 1H), 
6.26(dd, J=15.7, 8.5 HZ 1H), 5.13(ddd, J =8.5, 6.3, 3.4 Hz 1H), 3.45(dd, J =16.1, 6.3 Hz 1H), 
3.015(dd, J = 16.1, 3.4 Hz 1H); 13C NMR (75 MHz, CD2Cl2) δ 163.2, 143.8, 136.4, 135.5, 135.3, 
132.8, 132.6, 132.0, 128.9(2C), 127.1(2C), 125.0, 124.7, 58.3, 44.5; HRMS m/z calcd for 
C17H14N2O5S: 358.0623; found: 358.0625. 
(E)-4-(2-(furan-2-yl)vinyl)-1-(2-nitrophenylsulfonyl)azetidin-2-one (7i): 
To a solution of 0.0443 g (0.11 mmol, 0.1 eq.) of TMS-quinine and 0.287 g 
(0.94 mmol, 1.0 eq.) of imine in 10 ml of CH2Cl2 at -78°C was added 0.44 
ml(2.5 mmol, 2.5 eq.) of N, N-diisopropylethylamine. Then, a solution of 
0.142 ml (2.0 mmol, 2.0 eq.) of acetyl chloride in 0.5 ml CH2Cl2 was added 
over 2h via a syringe pump. After being stirred at -78°C for 5h, the reaction mixture was poured 
into 60 ml of CH2Cl2 and 15 ml of water. The organic layer was separated and subsequently 
washed with 15 ml saturated Na2CO3 solution and 10 ml of brine. The organic layers was dried 
(Na2SO4), filtered and concentrated in vacuo. Crystallization from CHCl3/hexane gave 0.241 g 
(74%)  of the title compound as yellow powder: mp 113-115°C; IR(KBr): 1703, 1543, 1368, 
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1249, 1180, 1151, 1126, 998 cm-1; 1H NMR (300 MHz, CDCl3) δ8.47-8.43( m, 1H), 7.79-
7.75( m, 3H), 7.42(dd, J=1.8, 0.8 HZ 1H), 6.43(d, J=3.2 HZ 1H), 6.36(dd, J=3.2, 1.8 HZ 1H), 
6.21(ddd, J =9.4, 5.9, 3.2 Hz 1H), 6.02(d, J=5.9 HZ 1H), 5.98(ddd, J =7.7, 5.6, 2.2 Hz 1H), 
3.39(dd, J=21.1, 2.2 HZ 1H), 3.04(ddd, J=21.1, 5.6, 0.8 HZ 1H) ; 13C NMR (75 MHz, CDCl3) δ 
168.4, 150.9, 143.6, 135.5, 134.9, 133.2, 132.1, 124.7, 124.6, 123.0, 110.8, 109.1, 54.9, 34.7; 
HRMS m/z calcd for C15H12N2O6S: 348.0416; found: 348.0416. 
(3R,4S)-3-methyl-1-(4-nitrophenylsulfonyl)-4-phenylazetidin-2-one 
(8a): To a solution of 0.0865 g (0.22 mmol, 0.1 eq.) of TMS-quinine and 
0.578 g (1.99 mmol, 1.0 eq.) of imine in 15 ml of CH2Cl2 at -78°C was 
added 0.88 ml(5.0 mmol, 2.5 eq.) of N, N-diisopropylethylamine. Then, a 
solution of 0.350 ml (4.0 mmol, 2.0 eq.) of acetyl chloride in 1.0 ml CH2Cl2 was added over 2h 
via a syringe pump. After being stirred at -78°C for 14h, the reaction mixture was poured into 50 
ml of EtOAc and 15 ml of water. The organic layer was separated and subsequently washed with 
15 ml saturated Na2CO3 solution and 10 ml of brine. The organic layers was dried (Na2SO4), 
filtered and concentrated in vacuo. Crystallization from CH2Cl2/hexane gave 0.593 mg (86%) of 
the mixture of two diastereomers as pale yellow powder. Carefully recrystalization from 
CH2Cl2/hexane gave 81.6 mg (11.8%) title compound as pale yellow prisms. The mother liquid 
was removed  organic solvent in vacuo. The resulting mixture of diastereomers was separated by 
ISCO (15-30% 6min, 30% 15 min, EtOAc/Hexane), which gave 0.084 g (12%) title compound 
as pale yellow powder. mp 160-161 °C; Separation of  the enantiomers by Chiral HPLC (Daicel 
ChiracelTM AS-H column , flow rate 0.5 ml/min, 50% iPrOH, 50% hexane, Tr 22.1 (S) and 26.8 
(R) min) provided the enantiomer ratio: (R): (S) =95.5: 4.5 (91 % ee); [α]D -97° (c 0.80, 
DMF);IR(KBr): 1806, 1535, 1368, 1351, 1168, 1138, 1106, 1084, 740 cm-1; 1H NMR (300 MHz, 
N
O S
O
O
NO2
Me
 48 
CDCl3) δ8.25( d, J=9.1 Hz 2H), 7.85( d, J=9.1 Hz 2H), 7.40-7.32 (m, 3H), 7.20-7.16 (m, 2H), 
4.73 (d, J=2.9 HZ 1H), 3.29(qd, J =7.5, 3.2, Hz 1H), 1.44(d, J=7.4 HZ, 3H); 13C NMR (75 MHz, 
CD2Cl2) δ 167.7, 151.2, 144.6, 135.9, 129.7, 129.3 (2C), 129.1 (2C), 127.3 (2C), 124.7 (2C), 
65.9, 55.2, 12.7; HRMS m/z calcd for C13H10N2O4S: 291.0440; found:291.0438. 
(3R,4R)-3-methyl-1-(4-nitrophenylsulfonyl)-4-phenylazetidin-2-one 
(8a’): The rest mixture of diastereomers was separated by ISCO. 0.098 g 
(14%) title compound was gained as pale yellow powder: mp 144-146 
°C; Separation of  the enantiomers by Chiral HPLC  (Daicel ChiracelTM 
AS-H column , flow rate 0.5 ml/min, 50% iPrOH, 50% hexane, Tr 22.0 
(R) and 37.9 (S) min) provided the enantiomer ratio: (R) : (S) =99.5: 0.5 (98 % ee); [α]D +144° 
(c 0.51, DMF); IR(KBr): 1798, 1533, 1368, 1350, 1180, 1136, 1086, 1051, 739 cm-1; 1H NMR 
(300 MHz, CDCl3) δ8.36( d, J=8.6 Hz 2H), 8.05( d, J=8.6 Hz 2H), 7.38-7.32 (m, 3H), 7.14-7.11 
(m, 2H), 5.29 (d, J=6.8 HZ 1H), 3.71(qd, J =14.8, 7.3, Hz 1H), 0.83 (d, J=7.7 HZ, 3H); 13C NMR 
(75 MHz, CD2Cl2) δ 167.9, 151.4, 144.6, 133.8, 129.7, 129.4 , 129.0, 127.6, 124.9, 62.0, 51.1, 
9.6; HRMS m/z calcd for C13H10N2O4S: 291.0440; found:291.0438. 
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(3R,4S)-4-(4-fluorophenyl)-3-methyl-1-(4-
nitrophenylsulfonyl)azetidin-2-one (8b): To a solution of 0.0888 g 
(0.22 mmol, 0.1 eq.) of TMS-quinine and 0.774 g (2.51 mmol, 1.0 eq.) of 
imine in 15 ml of CH2Cl2 at -78°C was added 0.88 ml (5.0 mmol, 2.5 eq.) 
of N, N-diisopropylethylamine. Then, a solution of 0.350 ml (4.0 mmol, 
2.0 eq.) of acetyl chloride in 1.0 ml CH2Cl2 was added over 2h via a syringe pump. After being 
stirred at -78°C for 14h, the reaction mixture was poured into 50 ml of EtOAc and 15 ml of 
water. The organic layer was separated and subsequently washed with 15 ml saturated Na2CO3 
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solution and 10 ml of brine. The organic layers was dried (Na2SO4), filtered and concentrated in 
vacuo. Crystallization from CH2Cl2/hexane gave 0.447 g (49%) of the title compound as pale 
yellow powder. The mother liquid was remove the solvent in vacuo and recrystallized from 
CH2Cl2/hexane, which gave 0.356 g mixture of diastereomers. The mixture was separated by 
ISCO (5-15% 5 min, 15-25% 5 min, 25% 12 min, EtOAc/Hexane). Another 0.064 g (7%) title 
compound was obtained. mp 162-163 °C; Separation of  the enantiomers by Chiral HPLC 
(Daicel ChiracelTM  AS-H  column , flow rate 0.5 ml/min, 50% iPrOH, 50% hexane, Tr 23.4 (R) 
and 28.8 (S) min) provided the enantiomer ratio: (R) : (S) =99: 1 (98 % ee); [α]D -136° (c 0.84, 
DMF); IR(KBr): 1806, 1609, 1535, 1512, 1367, 1350, 1236, 1168, 1084, 893, cm-1; 1H NMR 
(300 MHz, CDCl3) δ8.30 ( d, J=8.8 Hz, 2H), 7.88 ( d, J=8.8 Hz, 2H), 7.26-7.21 (m, 2H), 7.08-
6.99 (m, 2H), 4.69(d, J=3.3 HZ 1H), 3.27 (qd, J =7.4, 3.3 Hz 1H), 1.36 (d, J=7.7 HZ, 3H); 13C 
NMR (75 MHz, CD2Cl2) δ 167.5, 165.0, 161.7, 151.7, 144.4, 131.8, 129.1, 129.0, 128.9 (2C), 
124.7 (2C), 116.3, 116.0, 65.0, 55.2, 12.5; HRMS m/z calcd for C16H13N2O5S: 364.0529; 
found:364.0532. 
(3R,4R)-4-(4-fluorophenyl)-3-methyl-1-(4-
nitrophenylsulfonyl)azetidin-2-one (8b’): The mixture was separated 
by ISCO and obtained 0.120 g (13%) title compound as pale yellow 
powder. mp 164-165 °C; Separation of  the enantiomers by Chiral 
HPLC(Daicel ChiracelTM  AS-H  column , flow rate 0.5 ml/min, 50% 
iPrOH, 50% hexane, Tr 20.2 (R) and 25.4 (S) min) provided the enantiomer ratio: (R) : (S) 
=99.5 : 0.5 (99 % ee); [α]D +209° (c 0.82, DMF); IR(KBr): 1801, 1608, 1534, 1512, 1369, 1309, 
1231, 1179, 1135, 857 cm-1; 1H NMR (300 MHz, CDCl3) δ8.39 ( d, J=9.0 Hz, 2H), 8.10 ( d, 
J=9.0 Hz, 2H), 7.18-7.13 (m, 2H), 7.09-7.02 (m, 2H), 5.27 (d, J=6.8 HZ, 1H), 3.68 (qd, J =7.7, 
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6.8 Hz, 1H), 0.82 (d, J=7.7 HZ, 3H); 13C NMR (75 MHz, CD2Cl2) δ 167.6, 164.8, 161.5, 151.3, 
144.3, 129.7, 129.3 (2C), 129.2 (2C), 124.8, 116.0, 115.7, 116.0, 61.1, 50.9, 9.5; HRMS m/z 
calcd for C16H13N2O5S: 364.0529; found:364.0532. 
 
(3R,4S)-4-(biphenyl-4-yl)-3-methyl-1-(4-nitrophenylsulfonyl)azetidin-2-
one (8d): To a solution of 0.0861 g (0.22 mmol, 0.1 eq.) of TMS-quinine 
and 0.730 g (2.0 mmol, 1.0 eq.) of imine in 15 ml of CH2Cl2 at -78°C was 
added 0.88 ml (5.0 mmol, 2.5 eq.) of N, N-diisopropylethylamine. Then, a solution of 0.350 ml 
(4.0 mmol, 2.0 eq.) of acetyl chloride in 1.0 ml CH2Cl2 was added over 2h via a syringe pump. 
After being stirred at -78°C for 14h, the reaction mixture was poured into 50 ml of EtOAc and 15 
ml of water. The organic layer was separated and subsequently washed with 15 ml saturated 
Na2CO3 solution and 10 ml of brine. The organic layers was dried (Na2SO4), filtered and 
concentrated in vacuo. Crystallization from CH2Cl2/hexane gave 0.561 g (66%) of the mixture of 
diastereomers as pale yellow powder. The mixture was separated by ISCO (5-15 % 5 min, 15-30 
% 5 min, 30 % 12 min, EtOAc/Hexane). 0.105 g (12.4 %) title compound was obtained as pale 
yellow powder: mp 150-152 °C; Separation of  the enantiomers by Chiral HPLC(Daicel 
ChiralpakTM  AD  column , flow rate 1.0 ml/min, 40% iPrOH, 60% hexane, Tr 12.2 (R) and 14.5 
(S) min) provided the enantiomer ratio: (R) : (S) =99.5: 0.5 (99 % ee); [α]D -215° (c 1.00, DMF); 
IR(KBr): 1798, 1542, 1377, 1124, 1055, 845 cm-1; 1H NMR (300 MHz, CDCl3) δ 8.10 ( d, J=7.5 
Hz, 1H), 7.82-7.75 (m, 2H), 7.67-7.53 (m, 6H), 7.50-7.37 (m, 4H), 5.06 (d, J=3.2 HZ, 1H), 3.39 
(qd, J =7.4, 3.3 Hz, 1H), 1.47 (d, J=7.4 HZ, 3H); 13C NMR (75 MHz, CDCl3) δ 167.0, 142.2, 
140.3, 135.3, 135.1, 132.7, 132.4, 131.7, 129.0 (2C), 127.8 (2C), 127.2 (2C), 127.1 (2C), 124.6, 
66.3, 55.5, 12.6; HRMS m/z calcd for C22H18N2O5S: 422.0936; found:422.0934. 
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(3R,4R)-4-(biphenyl-4-yl)-3-methyl-1-(2-nitrophenylsulfonyl)azetidin-2-
one (8d’): The mixture of diastereomers was separated by ISCO (5-15 % 5 
min, 15-30 % 5 min, 30 % 12 min, EtOAc/Hexane). 0.186 g (22.1 %) title 
compound was obtained as pale yellow powder: mp 156-158 °C; Separation 
of  the enantiomers by Chiral HPLC (Daicel ChiralpakTM AD column , flow rate 1.0 ml/min, 
40% iPrOH, 60% hexane, Tr 20.9 (R) and 13.1 (S) min) provided the enantiomer ratio: (R) : (S) 
=92.5: 7.5 (85 % ee); [α]D +338° (c 1.07, DMF); IR(KBr): 1802, 1543, 1370, 1174, 1129, 852 
cm-1; 1H NMR (300 MHz, CDCl3) δ 8.28 ( d, J=7.4 Hz, 1H), 7.84-7.76 (m, 3H), 7.61-7.57 (m, 
4H), 7.49-7.34 (m, 5H), 5.66 (d, J=6.7 HZ, 1H), 3.81 (qd, J =7.6, 3.8 Hz, 1H), 0.96 (d, J=7.6 HZ, 
3H); 13C NMR (75 MHz, CDCl3) δ 167.1, 148.0, 141.5, 140.2, 135.2, 132.9, 132.8, 132.4, 131.5, 
128.8 (2C), 127.6, 127.4 (2C), 127.3 (2C), 127.0 (2C), 124.5, 62.6, 50.6, 9.7; HRMS m/z calcd 
for C22H18N2O5S: 422.0936; found:422.0934. 
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Table 1.  Crystal data and structure refinement for 8a. 
Identification code  xu1110s 
Empirical formula  C16 H14 N2 O5 S 
Formula weight  346.35 
Temperature  200(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1) 
Unit cell dimensions a = 8.4942(5) Å 　α= 90°. 
 b = 7.0841(4) Å 　β= 92.3830(10)°. 
 c = 13.1341(8) Å 　γ= 90°. 
Volume 789.64(8) Å3 
Z 2 
Density (calculated) 1.457 Mg/m3 
Absorption coefficient 0.235 mm-1 
 52 
F(000) 360 
Crystal size 0.45 x 0.21 x 0.16 mm3 
Theta range for data collection 1.55 to 32.49°. 
Index ranges -12<=h<=12, -10<=k<=10, -19<=l<=18 
Reflections collected 10445 
Independent reflections 5341 [R(int) = 0.0179] 
Completeness to theta = 32.49° 98.0 %  
Absorption correction Sadabs 
Max. and min. transmission 0.9634 and 0.9018 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5341 / 1 / 274 
Goodness-of-fit on F2 1.110 
Final R indices [I>2sigma(I)] R1 = 0.0494, wR2 = 0.1217 
R indices (all data) R1 = 0.0541, wR2 = 0.1255 
Absolute structure parameter 0.05(6) 
Largest diff. peak and hole 0.500 and -0.160 e.Å-3 
 
3.3 DERIVATIZATION OF β-LACTAM 
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(R)-methyl-3-(4-nitrophenylsulfonamido)-3-
phenylpropanoate (9): To a solution of 0.182 g (3.4 mmol, 1.7 eq.) 
of NaOMe in 6 ml of MeOH at -78°C was added 0.664 g (2 mmol) 
of lactam in a mixture of 4ml CH2Cl2 and 2 ml MeOH dropwisely. 
After being stirred at -78°C for 1.5 hours, the reaction mixture was 
poured into 60 ml of CH
HN
S
O
O
NO2
O
MeO
Cl2 2 and 15 ml of water. The organic layer was separated and 
subsequently washed with 10 ml of brine. The organic layers was dried (Na2SO4), filtered and 
concentrated in vacuo. Then, it was purified by chromatography(40% EtOAC/Hexane) and  gave 
0.604 g (83%)  of the title compound as pale yellow powder: mp 138-140°C; Separation of  the 
enantiomers by Chiral HPLC (Daicel ChiracelTM  OD-H column , flow rate 1.0 ml/min, 10% 
iPrOH, 90% hexane, Tr 53.4 (R) and 45.9 (S) min) provided the enantiomer ratio: (R) : (S) =95.7: 
4.3(83% ee); [α]D +38.3°(c 1.15, DMF);  IR(KBr): 1717, 1609, 1522, 1435, 1350, 1207, 1166, 
1092, 1071cm-1 1; H NMR (300 MHz, CDCl3) δ 8.12( d, J=9.0 HZ, 2H), 7.78(d, J=9.0 HZ, 2H), 
7.20-7.11(m, 3H), 7.09-7.04(m, 2H), 6.27(d, J=3.2 HZ 1H), 4.86(m 1H), 3.63(S, 3H), 2.85(d, 
J=6.2 HZ, 1H) ; 13C NMR (75 MHz, CDCl3) δ 171.3, 149.9，146.6，138.7，128.9(2C)，
128.5(2C), 128.4 ，  126.7(2C) ， 124.1(2C, 55.1, 52.3 ， 41.3; HRMS m/z calcd for 
C +16H16N O SNa (M+Na ): 387.0521; found: 387.0627. 2 6
(R)-methyl-3-amino-3-phenylpropanoate (10): A mixture of 10 
(100.8 mg, 0.278 mmol) and K2CO3 in 2ml DMF was added PhSH (36.8 
mg, 0.333 mmol). The mixture was stirred at 50°C for 5 hours. Then, the 
mixture was cooled to room temperature. Then, 3 ml saturated NaHCO
NH2O
MeO
3 solution was added. The 
mixture was diluted with 15 ml Et O and the separated organic phase was washed with H2 2O (4*2 
ml). The aqueous phase was washed with 20 ml CH Cl . The organic layers was dried (Na2 2 2SO ), 4
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filtered and concentrated in vacuo. Then, it was purified by chromatography(50% 
EtOAC/Hexane) and gave 20.8 mg (42%) of the title compound. Because this compound is 
known,4 full characterization wasn’t given. 1H NMR (300 MHz, CDCl3) δ 7.38-7.23 (m, 5H), 
4.44 (d, J= 8.9, 6.7 Hz, 1H), 3.69 (s, 2H), 2.72-2.63 (m, 2H), 1.87 (br, 2H). 
 
R)-methyl-3-((R)-3-(4-nitrophenylsulfonamido)-
3-phenylpropanamido)-3-phenylpropanoate (11): 
A mixture of 52.0 mg of lactam(0.157 mmol, 1 eq.) 
and 33.2 mg of amino ester(0.185 mmol, 1.2 eq.) in 3ml of DMF at 50°C was stirred for 4 hours. 
The mixture was cooled to room temperature. The organic solvent was removed in vacuo. The 
concentration was purified by chromatography(40% EtOAC/Hexane) and  gave 60.3 mg (75%)  
of the title compound as white needles: mp 67-69°C; Separation of  the enantiomers by Chiral 
HPLC(Daicel Chiralpak
O
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TM AD column , flow rate 1.0 ml/min, 40% iPrOH, 60% hexane, Tr 30.9 
(R) provided the enantiomer ratio: (R) : (S) =99.5: 0.5 (> 99% ee); [α]D +41°;  IR(KBr): 3299, 
1735, 1647, 1531, 1438, 1350, 1165, 1093, 1064cm-1cm-1 1; H NMR (300 MHz, CDCl3) δ 8.01( d, 
J=8.6 HZ, 2H), 7.71(d, J=8.5 HZ, 2H), 7.31-7.21(m, 4H), 7.13-7.02(m, 6H), 6.88-6.86(m, 1H), 
5.30(dd, J=13.9, 6.1HZ, 1H), 4.84(dd, J=12.5, 6.1HZ, 1H), 3.55(S, 3H), 2.81-2.62(m, 4H) ; 13C 
NMR (75 MHz, CDCl3) δ 171.7, 169.6, 149.7, 146.8, 140.0, 139.1, 129.0(2C), 128.7(2C), 
128.4(2C), 128.1, 128.0, 126.9(2C), 126.3(2C), 123.9(2C), 55.8, 52.1, 49.9, 43.1, 39.6; HRMS 
m/z calcd for C +25H25N O SNa (M+Na ):534.1311; found: 534.1305. 3 7
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